Market Research Report
Asia Pacific Bone Densitometer Market Forecast 2019-2027
|Published by||Inkwood Research||Product code||910170|
|Published||Content info||95 Pages
Delivery time: 2-3 business days
|Asia Pacific Bone Densitometer Market Forecast 2019-2027|
|Published: September 6, 2019||Content info: 95 Pages||
The bone densitometer market in the Asia Pacific is expected to grow with a CAGR of 4.43% from 2019 to 2027. The market in the Asia Pacific accounted for revenue of $XX million in 2018 and is estimated to reach $XX million by 2027. Several factors, such as increasing geriatric population, and rising demand for advanced healthcare services in the emerging countries of the region, are driving the growth of the bone densitometer market.
Developing countries like India, Australia, Japan, China, and South Korea are studied in the Asia Pacific bone densitometer market. The report also includes the Rest of Asia Pacific segment that consists of remaining APAC countries. China's aging population has been majorly affected by osteoarthritis and osteoporosis, which is influencing the market growth of bone densitometer. The World Bank report states that in 2018, about 67.5 million people in China were affected by osteoporosis and osteoarthritis. Further, patients in the country are opting for a modern approach for the treatment of chronic knee and hip pain such as allografts and autografts as compared to the traditional approach. As a result of this, the bone densitometer market is propelling at a significant pace.
Medilink, Osteometer Meditech Inc., Medonica Co. Ltd., Hologic, Inc., and Swissray International Inc. are some of the notable players operating in the bone densitometer market. The existing companies are following several strategies to hold a strong position in the market, such as new product development, collaborative research activities, and others.